Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: J Trauma Acute Care Surg. 2021 Feb 1;90(2):257–267. doi: 10.1097/TA.0000000000003029

Figure 4. Select inflammatory and immunosuppressive biomarker trajectories by endotype.

Figure 4.

Log-transformed circulating (A) IL-6, (B) IL-8, (C) IL-10 and (D) soluble programmed death ligand 1 (sPD-L1) levels measured from peripheral blood at 0.5, 1, 4, 7 and 14 days after injury and classified by endotype (iA, iB, iC).